fbpx
QQQ
+ -0.01
284.20
+ 0%
DIA
+ 1.76
280.21
+ 0.62%
SPY
+ 1.99
340.66
+ 0.58%
TLT
-1.65
160.35
-1.04%
GLD
-1.83
182.49
-1.01%

Europe: The Next Big Cannabis Market?

October 22, 2019 4:50 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

While the Canadian cannabis market has had some hiccups and the U.S. market continues to face legal hurdles, the rest of the world, and particularly Europe, is starting to emerge with fast-growing potential, officials at three globally engaged cannabis companies said Tuesday.

“The real future of this industry is going to emerge as a global market,” W. Scott Boyes, CEO of MPX International Corp (OTC:MPXOF) said during a panel discussion of European cannabis markets at the Benzinga Cannabis Capital Conference in Chicago.

'Real Opportunities' Overseas

Boyes, Sundial Growers Inc. (NASDAQ:SNDL) CFO Jim Keough and Robert Kelly, director of investor relations for Aurora Cannabis Inc. (NYSE:ACB) all said Europe is ripe for a similar explosion in interest, investment and legalization that Canada and the U.S. saw a couple of years ago.

Aurora was chosen this year as one of three companies that will provide cannabis to the German government for that country’s medical marijuana program and announced in the summer that it has won a contract to supply medical cannabis in Italy, Kelly said.

“And we’re excited for opportunities in France and Ireland, they’re very close and we are working with regulators there,” the exec said.

Luxembourg and Poland are also interesting potential markets for cannabis companies, he said.

Sundial has started to put some focus on the United Kingdom, where it has acquired the largest potted plant and edible herb producer.

“What we’re seeing in the U.K. is probably where Canada was two or three years ago,” Keough said.

Boyes said much of Europe is at the same point on the development trendline.

“These countries are going through the same evolution we did here in North America,” the MPX CEO said, noting that most are focused on medical cannabis, with adult use likely further down the road.

While the industry “seems to have flatlined a little in Canada,” Boyes said, “real opportunities exist globally.”

Related Links:

Canopy Growth Expands In UK, Luxembourg Medical Marijuana Markets

Europe's Medical Cannabis Programs: Countries To Watch

Photo courtesy of Aurora.


Related Articles

Business Insights From Curaleaf's Boris Jordan: 'Go With Your First Instinct'

"Once you start to over-analyze stuff, you do mess it up," Boris Jordan, the Executive Chairman of Curaleaf Holdings Inc. (OTCQX: CURLF) and Chief Investment Officer at Measure8, told Benzinga's Jason Raznick. read more

Why Vertically-Integrated 1933 Industries Is Positioned To Outperform

1933 Industries joined a panel of cannabis movers and shakers from across the globe at Benzinga’s Virtual Cannabis Capital Conference on October read more

Do Cannabis Investors Need To Know About The Science Behind The Plant?

“There’s a huge misconception that everything in cannabis is the same, and every company in cannabis is doing the same thing,” says Aras Azadian, CEO of Avicanna (TSX: AVCN) (OTCQX: AVCNF), a Toronto-based cannabinoid and biopharmaceutical company. read more

How Berner's Cookies Preserves Cannabis Quality Across State Lines

As a cannabis entrepreneur, getting complimented by Bruce Linton can surely be something to brag about. read more

SLANG Worldwide's Products Will Be Back In The California Market

SLANG Worldwide Inc. (OTCQB: SLGWF), a leading global cannabis consumer packaged goods company, announced Thursday that they are re-entering the California market after a strategic decision to pull back in 2019. read more